LifeMD, Inc. (LFMDP) vs NervGen Pharma Corp. Common stock (NGEN)

A side-by-side comparison of LifeMD, Inc. and NervGen Pharma Corp. Common stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — LFMDP vs NGEN

growth of $100 · dividends reinvested · last 1y
LFMDP +11.1% (+11.1%/yr)NGEN -57.6% (-57.6%/yr)LFMDP compounded faster over this window
406080100120140Start $1002026$111$42
LFMDP NGEN

LFMDP vs NGEN: by the numbers

  • •NGEN is the larger company ($148M vs $148M market cap).
  • •Both run net losses; NGEN's is the smaller (0.00% vs -10.40% net margin).
  • •LFMDP pays a dividend (9.71% yield), while NGEN has no payments in the available dividend history.

Metrics side by side

Valuation

MetricLFMDPNGEN
P/S ratio0.72N/A
P/B ratio18.5712.19

Profitability

MetricLFMDPNGEN
Gross margin85.91%0.00%
Operating margin-9.35%0.00%
Net margin-10.40%0.00%
ROE-266.86%-397.38%
ROIC-143.97%-223.90%

Dividends

MetricLFMDPNGEN
Dividend yield9.71%N/A

Growth (annualized)

MetricLFMDPNGEN
Revenue CAGR (5Y)26.00%N/A
Total return CAGR (5Y)10.80%N/A

Frequently asked

Does LFMDP or NGEN pay a bigger dividend?
LFMDP pays a dividend (9.71% yield), while NGEN has no payments in the available dividend history.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.